Hong Kong drives trials for breast cancer, eye treatments across Greater Bay Area

AI Summary

Hong Kong, together with Shenzhen and a pharmaceutical start-up, is launching large-scale clinical trials for two US-developed treatments targeting breast cancer and a degenerative eye disease. This collaboration emphasizes the Greater Bay Area's role in advancing medical research and innovation.

Two US-developed treatments for breast cancer and a degenerative eye disease will undergo large-scale clinical trials in the Greater Bay Area in a collaboration involving Hong Kong, Shenzhen and a pharmaceutical start-up founded by a former lawmaker. The agreement was formalised on Tuesday when Health Hope Pharma founder Dr Dennis Lam Shun-chiu signed a memorandum of understanding with the Greater Bay Area International Clinical Trial Institute (GBAICTI) and its Shenzhen counterpart, Greater Bay...